Breaking News Instant updates and real-time market news.

KALV

KalVista

$28.35

2.05 (7.79%)

07:05
03/20/19
03/20
07:05
03/20/19
07:05

KalVista initiated with a Buy at Needham

Needham analyst Serge Belanger initiated KalVista with a Buy rating and a price target of $35, saying the company is on track to become the "future leader of oral Kallikrein inhibitors" as it develops "novel treatments for hereditary angioedema and diabetic macular edema". The analyst notes that KalVista's KVD900 lead drug candidate has demonstrated a pharmacokinetics profile that "rivals injectables" and its tolerability profile is devoid of gastro-intestinal adverse events. Belanger expects the company's phase 2 results in late-2019 to confirm KVD900's best-in-class potential for the $1B acute HAE treatment market.

KALV KalVista
$28.35

2.05 (7.79%)

07/10/18
ROTH
07/10/18
INITIATION
Target $20
ROTH
Buy
KalVista initiated with a Buy at Roth Capital
Roth Capital analyst Jotin Marango started KalVista with a Buy rating and $20 price target as he expects shares to outperform following upcoming updates from the clinical programs in hereditary angioedema and diabetic macular edema.
09/21/18
CANT
09/21/18
INITIATION
Target $32
CANT
Overweight
KalVista initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan last night initiated coverage of KalVista with an Overweight rating and $32 price target. The analyst, who started coverage on seven Neuro-Innovator and Platform-Enabled Therapeutic companies, believes that "biotech has entered a golden age of innovation and productivity across many therapeutic areas."
10/15/18
STFL
10/15/18
INITIATION
Target $33
STFL
Buy
KalVista initiated with a Buy at Stifel
Stifel analyst Paul Matteis started KalVista Pharmaceuticals (KALV) with a Buy rating and $33 price target. The company's lead asset KVD900, an oral plasma kallikrein inhibitor, has a "realistic shot" at being a best-in-class acute therapy for hereditary angioedema, Matteis tells investors in a research note. He thinks clinical results from competitor BioCryst (BCRX) "corroborate the viability of the oral kallikrein inhibitor approach but simultaneously leave room for improvement."
10/30/18
JEFF
10/30/18
INITIATION
Target $30
JEFF
Buy
KalVista initiated with a Buy at Jefferies
Jefferies analyst Maury Raycroft started KalVista with a Buy rating and $30 price target. The company's hereditary angioedema program has the potential to be the best-in-class oral HAE therapy in the acute setting with potentially some grey lines that may drive broader prophylactic use, Raycroft tells investors in a research note. He sees a buying opportunity at current share levels.

TODAY'S FREE FLY STORIES

WBA

Walgreens Boots Alliance

$62.35

0.09 (0.14%)

10:46
11/12/19
11/12
10:46
11/12/19
10:46
Recommendations
Walgreens Boots Alliance analyst commentary  »

Walgreens Boots could be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 22

    Nov

QSR

Restaurant Brands

$67.39

-0.15 (-0.22%)

10:45
11/12/19
11/12
10:45
11/12/19
10:45
Options
Restaurant Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
11/12/19
11/12
10:45
11/12/19
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

10:45
11/12/19
11/12
10:45
11/12/19
10:45
General news
Breaking General news story  »

8-Week Bill Announcement…

F

Ford

$9.11

0.03 (0.33%)

, GM

General Motors

$38.89

0.18 (0.46%)

10:38
11/12/19
11/12
10:38
11/12/19
10:38
Periodicals
Trump expected to extend deadline for EU car tariffs, Bloomberg says »

The Trump administration…

F

Ford

$9.11

0.03 (0.33%)

GM

General Motors

$38.89

0.18 (0.46%)

HMC

Honda

$29.35

0.15 (0.51%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$145.00

-0.07 (-0.05%)

TSLA

Tesla

$348.78

3.71 (1.08%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$16.21

0.1 (0.62%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 09

    Dec

  • 04

    Feb

KSS

Kohl's

$56.48

-0.56 (-0.98%)

10:35
11/12/19
11/12
10:35
11/12/19
10:35
Options
Kohl's put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

10:35
11/12/19
11/12
10:35
11/12/19
10:35
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

DIS

Disney

$139.04

2.3 (1.68%)

10:31
11/12/19
11/12
10:31
11/12/19
10:31
Hot Stocks
Disney says Disney+ 'exceeded our high expectations,' working on glitches »

Disney+ Help tweeted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$32.77

0.01 (0.03%)

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Options
Kraft Heinz call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Conference/Events
Roche to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 07

    Dec

REPL

Replimune Group

$17.24

0.11 (0.64%)

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Conference/Events
Replimune Group participates in a conference call with JPMorgan »

SMid Biotech Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

10:25
11/12/19
11/12
10:25
11/12/19
10:25
Conference/Events
UBS technology analysts to hold an analyst/industry conference call »

Technology Analysts…

LH

LabCorp

$165.45

-0.29 (-0.17%)

10:23
11/12/19
11/12
10:23
11/12/19
10:23
Syndicate
Breaking Syndicate news story on LabCorp »

LabCorp files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$47.57

1.39 (3.01%)

, TEVA

Teva

$9.36

0.03 (0.32%)

10:21
11/12/19
11/12
10:21
11/12/19
10:21
On The Fly
JPMorgan gets less bearish on Xerox among today's top calls on Wall Street »

Check out today's top…

CRWD

Crowdstrike

$47.57

1.39 (3.01%)

TEVA

Teva

$9.36

0.03 (0.32%)

AMRX

Amneal Pharmaceuticals

$2.69

0.05 (1.89%)

XRX

Xerox

$38.05

-0.28 (-0.73%)

HPQ

HP Inc.

$19.33

-0.31 (-1.58%)

AMAT

Applied Materials

$56.81

0.21 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 26

    Nov

  • 05

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

UCBJY

UCB

$0.00

(0.00%)

10:20
11/12/19
11/12
10:20
11/12/19
10:20
Conference/Events
UCB participates in a conference call with JPMorgan »

European Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$19.92

3.02 (17.87%)

10:18
11/12/19
11/12
10:18
11/12/19
10:18
On The Fly
Analysts see good odds of Amarin's Vascepa label expansion after docs posted »

Stifel analyst Derek…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
11/12/19
11/12
10:17
11/12/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARLO

Arlo Technologies

$2.84

0.18 (6.77%)

, CCC

Clarivate Analytics

$17.22

0.13 (0.76%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ARLO

Arlo Technologies

$2.84

0.18 (6.77%)

CCC

Clarivate Analytics

$17.22

0.13 (0.76%)

STOK

Stoke Therapeutics

$30.87

1.04 (3.49%)

BMRN

BioMarin

$75.96

0.72 (0.96%)

BIIB

Biogen

$291.50

-2.41 (-0.82%)

AMGN

Amgen

$223.35

2.66 (1.21%)

CTVA

Corteva

$27.06

0.32 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 07

    Dec

  • 09

    Dec

CSX

CSX

$72.89

-1.04 (-1.41%)

, ETN

Eaton

$91.78

-0.09 (-0.10%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Initiation
Fly Intel: Top five analyst downgrades »

Catch up on today's…

CSX

CSX

$72.89

-1.04 (-1.41%)

ETN

Eaton

$91.78

-0.09 (-0.10%)

AMRX

Amneal Pharmaceuticals

$2.71

0.07 (2.65%)

ALB

Albemarle

$67.47

-0.25 (-0.37%)

BOX

Box

$15.93

-0.52 (-3.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 26

    Nov

  • 12

    Dec

ARGO

Argo Group

$63.82

2.54 (4.14%)

, LYV

Live Nation

$64.79

0.32 (0.50%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

ARGO

Argo Group

$63.82

2.54 (4.14%)

LYV

Live Nation

$64.79

0.32 (0.50%)

RCII

Rent-A-Center

$23.13

0.78 (3.49%)

CRWD

Crowdstrike

$47.25

1.07 (2.32%)

TEVA

Teva

$9.40

0.07 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 12

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
11/12/19
11/12
10:16
11/12/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$138.17

1.43 (1.05%)

10:15
11/12/19
11/12
10:15
11/12/19
10:15
Periodicals
Disney tells CNBC streaming service launch exceeds 'high expectations' »

CNBC reported via Twitter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$5.90

-0.01 (-0.17%)

10:15
11/12/19
11/12
10:15
11/12/19
10:15
Options
Sprint put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

IDRA

Idera Pharmaceuticals

$2.29

0.06 (2.69%)

10:15
11/12/19
11/12
10:15
11/12/19
10:15
Conference/Events
Idera Pharmaceuticals participates in a conference call with JPMorgan »

SMid Biotech Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$138.25

1.51 (1.10%)

10:12
11/12/19
11/12
10:12
11/12/19
10:12
Periodicals
Disney working to fix Disney+ issues amid 'incredible response,' TechCrunch says »

Disney+ users have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.